Cancer metabolomics and the human metabolome database

Metabolites

Volumn 6, Issue 1, 2016, Pages

  Wishart, David S ^a,b   Mandal, Rupasri ^a   Stanislaus, Avalyn ^a   Ramirez Gaona, Miguel ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Biomarkers; Cancer metabolomics; Human Metabolome Database (HMDB); Metabolomics databases; Oncometabolites

Indexed keywords

2 HYDROXYGLUTARIC ACID; FUMARIC ACID; HYPOXIA INDUCIBLE FACTOR; SUCCINIC ACID; TUMOR MARKER;

CANCER GROWTH; CANCER RESEARCH; CARBON NUCLEAR MAGNETIC RESONANCE; DATA BASE; EPIGENETICS; HUMAN; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; MOLECULAR BIOLOGY; NEOPLASM; NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PROTEIN PROCESSING; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 85006216395     PISSN: None     EISSN: 22181989     Source Type: Journal    
DOI: 10.3390/metabo6010010     Document Type: Review

References (51)

1. Warburg, O.; Wind, F.; Negelein, E. The Metabolism of tumors in the body. J. Gen. Physiol. 1927, 8, 519–530. [CrossRef] [PubMed]
2. Vander Heiden, M.G.; Canltey, L.C.; Thompson, C.B. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 2009, 324, 1029–1033. [CrossRef] [PubMed]
3. Ward, P.S.; Patel, J.; Wise, D.R.; Abdel-Wahab, O.; Bennett, B.D.; Coller, H.A.; Cross, J.R.; Fantin, V.R.; Hedvat, C.V.; Perl, A.E. et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010, 17, 225–234. [CrossRef] [PubMed]
4. Wishart, D.S. Is cancer a genetic disease or a metabolic disease? EBioMedicine 2015, 2, 478–479. [CrossRef] [PubMed]
5. Kobayashi, T.; Nishiumi, S.; Ikeda, A.; Yoshie, T.; Sakai, A.; Matsubara, A.; Izumi, Y.; Tsumura, H.; Tsuda, M.; Nishisaki, H. et al. A novel serum metabolomics-based diagnostic approach to pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 2013, 22, 571–579. [CrossRef] [PubMed]
6. Beger, R.; Schnackenberg, L.; Holland, R.; Li, D.; Dragan, Y. Metabonomic models of human pancreatic cancer using 1d proton NMR spectra of lipids in plasma. Metabolomics 2006, 2, 125–134. [CrossRef]
7. Ganti, S.; Weiss, R.H. Urine metabolomics for kidney cancer detection and biomarker discovery. Metabolomics 2011, 29, 551–557. [CrossRef] [PubMed]
8. Wang, Q.; Gao, P.; Wang, X.; Duan, Y. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma. Clin. Chim. Acta 2014, 427, 79–85. [CrossRef] [PubMed]
9. Tian, Y.; Nie, X.; Xu, S.; Li, Y.; Huang, T.; Tang, H.; Wang, Y. Integrative metabonomics as potential method for diagnosis of thyroid malignancy. Sci. Rep. 2015, 5. [CrossRef] [PubMed]
10. Handa, H.; Usuba, A.; Maddula, S.; Baumbach, J.I.; Mineshita, M.; Miyazawa, T. Exhaled breath analysis for lung cancer detection using ion mobility spectrometry. PLoS ONE 2014, 9, e114555. [CrossRef] [PubMed]
11. Westhoff, M.; Litterst, P.; Freitag, L.; Urfer, W.; Bader, S.; Baumbach, J.I. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: Results of a pilot study. Thorax 2009, 64, 744–748. [CrossRef] [PubMed]
12. Mimmi, M.C.; Finato, N.; Pizzolato, G.; Beltrami, C.A.; Fogolari, F.; Corazza, A.; Esposito, G. Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry. Anal. Cell. Pathol. 2013, 36, 71–83. [CrossRef]
13. Wei, S.; Liu, L.; Zhang, J.; Bowers, J.; Gowda, G.A.N.; Seeger, H.; Fehm, T.; Neubauer, H.J.; Vogel, U.; Clare, S.E. et al. Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer. Mol. Oncol. 2013, 7, 297–307. [CrossRef] [PubMed]
14. Jobard, E.; Pontoizeau, C.; Blaise, B.J.; Bachelot, T.; Elena-Herrmann, B.; Trédan, O. A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer. Cancer Lett. 2014, 343, 33–41. [CrossRef] [PubMed]
15. Jiménez, B.; Mirnezami, R.; Kinross, J.; Cloarec, O.; Keun, H.C.; Holmes, E.; Goldin, R.D.; Ziprin, P.; Darzi, A.; Nicholson, J.K. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic “field-effects” enables colorectal cancer staging and prognostication. J. Proteome Res. 2013, 12, 959–968. [CrossRef] [PubMed]
16. Tan, B.; Qiu, Y.; Zou, X.; Chen, T.; Xi, G.; Cheng, Y.; Dong, T.; Zhao, L.; Feng, B.; Hu, X. et al. Metabonomics identifies serum metabolite markers of colorectal cancer. J. Proteome Res. 2013, 12, 3000–3009. [CrossRef] [PubMed]
17. Tripathi, P.; Kamarajan, P.; Somashekar, B.S.; MacKinnon, N.; Chinnaiyan, A.M.; Kapila, Y.L.; Rajendiran, T.M.; Ramamoorthy, A. Delineating metabolic signatures of head and neck squamous cell carcinoma: Phospholipase A2, a potential therapeutic target. Int. J. Biochem. Cell Biol. 2012, 44, 1852–1861. [CrossRef] [PubMed]
18. Wishart, D.S. Computational strategies for metabolite identification in metabolomics. Bioanalysis 2009, 1, 1579–1596. [CrossRef] [PubMed]
19. Wishart, D.S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A.C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhany, S. et al. HMDB: The Human Metabolome Database. Nucleic Acids Res. 2007, 35, D521–D526. [CrossRef] [PubMed]
20. Wishart, D.S.; Jewison, T.; Guo, A.C.; Wilson, M.; Knox, C.; Liu, Y.; Djoumbou, Y.; Mandal, R.; Aziat, F.; Dong, E. et al. HMDB 3.0—The Human Metabolome Database in 2013. Nucleic Acids Res. 2013, 41, D801–D807. [CrossRef] [PubMed]
21. Kanehisa, M.; Goto, S.; Sato, Y.; Kawashima, M.; Furumichi, M.; Tanabe, M. Data, information, knowledge and principle: Back to metabolism in KEGG. Nucleic Acids Res. 2014, 42, D19–D205. [CrossRef] [PubMed]
22. Caspi, R.; Billington, R.; Ferrer, L.; Foerster, H.; Vulcher, C.A.; Keseler, I.M.; Kothari, A.; Krummenacker, M.; Latendresse, M.; Mueller, L.A. et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res. 2015. [CrossRef]
23. NCBI Resource Coordinators. Database resources at the National Center for Biotechnology Information. Nucleic Acids Res. 2015, 43, D6–D17.
24. De Matos, P.; Alcantara, R.; Dekker, A.; Ennis, M.; Hastings, J.; Haug, K.; Spiteri, I.; Turner, S.; Steinbeck, C. Chemical Entities of Biological Interest: An update. Nucleic Acids Res. 2010, 38, D249–D254. [CrossRef] [PubMed]
25. Berman, H.; Henrick, K.; Nakamura, H.; Markley, J.L. The worldwide Protein Data Bank (wwPDB): Ensuring a single, uniform archive of PDB data. Nucleic Acids Res. 2007, 35, D301–D303. [CrossRef] [PubMed]
26. The UniProt Consortium. UniProt: A hub for protein information. Nucleic Acids Res. 2015, 43, D204–D212.
27. Ulrich, E.L.; Akutsu, H.; Doreleijers, J.F.; Harano, Y.; Ioannidis, Y.E.; Lin, J.; Livny, M.; Mading, S.; Maziuk, D.; Miller, Z. et al. BioMagResBank. Nucleic Acids Res. 2008, 36, D402–D408. [CrossRef] [PubMed]
28. Smith, C.A.; O’Maille, G.; Want, E.J.; Qin, C.; Trauger, S.A.; Brandon, T.R.; Custodio, D.E.; Abagyan, R.; Siuzdak, G. METLIN: A metabolite mass spectral database. Ther. Drug Monit. 2005, 27, 747–751. [CrossRef] [PubMed]
29. Horai, H.; Arita, M.; Kanaya, S.; Nihei, Y.; Ikeda, T.; Suwa, K.; Ojima, Y.; Tanaka, K.; Tanaka, S.; Aoshima, K.; et al. MassBank: A public repository for sharing mass spectral data for life sciences. J. Mass Spectrom. 2010, 45, 703–714. [CrossRef] [PubMed]
30. Mandal, R.; Guo, A.C.; Chaudhary, K.K.; Liu, P.; Yallou, F.S.; Dong, E.; Aziat, F.; Wishart, D.S. Multi-platform characterization of the human cerebrospinal fluid metabolome: A comprehensive and quantitative update. Genome Med. 2012, 4, 38–48. [CrossRef] [PubMed]
31. Psychogios, N.; Hau, D.D.; Peng, J.; Guo, A.C.; Mandal, R.; Bouatra, S.; Sinelnikov, I.; Krishnamurthy, R.; Eisner, R.; Gautam, B. et al. The Human serum metabolome. PLoS ONE 2011, 6, e16957. [CrossRef] [PubMed]
32. Bouatra, S.; Aziat, F.; Mandal, R.; Guo, A.C.; Wilson, M.R.; Knox, C.; Bjorndahl, T.C.; Krishnamurthy, R.; Saleem, F.; Liu, P. et al. The human urine metabolome. PLoS ONE 2013, 8, e73076. [CrossRef] [PubMed]
33. Dame, Z.T.; Aziat, F.; Mandal, R.; Krishnamurthy, R.; Bouatra, S.; Borzouie, S.; Guo, A.C.; Sajed, T.; Deng, L.; Lin, H. et al. The human saliva metabolome. Metabolomics 2015, 11, 1864–1883. [CrossRef]
34. Law, V.; Knox, C.; Djoumbou, Y.; Jewison, T.; Guo, A.C.; Liu, Y.; Maciejewski, A.; Arndt, D.; Wilson, M.; Neveu, V. et al. DrugBank 4.0: Shedding new light on drug metabolism. Nucleic Acids Res. 2014, 42, D1091–D1097. [CrossRef] [PubMed]
35. Wishart, D.S.; Arndt, D.; Pon, A.; Sajed, T.; Guo, A.C.; Djoumbou, Y.; Knox, C.; Wilson, M.; Liang, Y.; Grant, J. et al. T3DB: The toxic exposome database. Nucleic Acids Res. 2015, 43, D928–D934. [CrossRef] [PubMed]
36. Jewison, T.; Su, Y.; Disfany, F.M.; Liang, Y.; Knox, C.; Maciejewski, A.; Poelzer, J.; Huynh, J.; Zhou, Y.; Arndt, D. et al. SMPDB 2.0: Big improvements to the Small Molecule Pathway Database. Nucleic Acids Res. 2014, 42, D1091–D1097. [CrossRef] [PubMed]
37. Pon, A.; Jewison, T.; Su, Y.; Liang, Y.; Knox, C.; Maciejewski, A.; Wilson, M.; Wishart, D.S. Pathways with PathWhiz. Nucleic Acids Res. 2015, 43, W552–W559. [CrossRef] [PubMed]
38. Fan, J.; Teng, X.; Liu, L.; Mattaini, K.R.; Looper, R.E.; Vander Heiden, M.G.; Rabinowitz, J.D. Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate. ACS Chem. Biol. 2015, 10, 510–516. [CrossRef] [PubMed]
39. Boroughs, L.K.; DeBerardinis, R.J. Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol. 2015, 17, 351–359. [CrossRef] [PubMed]
40. Eisner, R.; Stretch, C.; Eastman, T.; Xia, J.; Hau, D.; Damaraju, S.; Greiner, R.; Wishart, D.S.; Baracos, V.E. Learning to predict cancer-associated skeletal muscle wasting from 1H-NMR profiles of urinary metabolites. Metabolomics 2011, 7, 25–34. [CrossRef]
41. Ravanbakhsh, S.; Liu, P.; Bjordahl, T.C.; Mandal, R.; Grant, J.R.; Wilson, M.; Eisner, R.; Sinelnikov, I.; Hu, X.; Luchinat, C. et al. Accurate, Fully-Automated NMR Spectral Profiling for Metabolomics. PLoS ONE 2015, 10, e0124219. [CrossRef] [PubMed]
42. Xia, J.; Sinelnikov, I.; Han, B.; Wishart, D.S. MetaboAnalyst 3.0—Making metabolomics more meaningful. Nucleic Acids Res. 2015, 43, W251–W257. [CrossRef] [PubMed]
43. Allen, F.; Greiner, R.; Wishart, D. Competitive fragmentation modeling of ESI-MS/MS spectrafor putative metabolite identification. Metabolomics 2015, 11, 98–110. [CrossRef]
44. Allen, F.; Pon, A.; Wilson, M.; Greiner, R.; Wishart, D. CFM-ID: A web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra. Nucleic Acids Res. 2014. [CrossRef] [PubMed]
45. Xia, J.; Fjell, C.D.; Mayer, M.L.; Pena, O.M.; Wishart, D.S.; Hancock, R.E.W. INMEX—A web-based tool for integrative meta-analysis of expression data. Nucleic Acids Res. 2013, 41, W63–W70. [CrossRef] [PubMed]
46. Wu, H.; Xue, R.; Tang, Z.; Deng, C.; Liu, T.; Zeng, H.; Sun, Y.; Shen, X. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry. Anal. Bioanal. Chem. 2010, 396, 1385–1395. [CrossRef] [PubMed]
47. Mörén, L.; Bergenheim, A.T.; Ghasimi, S.; Brännström, T.; Johansson, M.; Antti, H. Metabolomic screening of tumor tissue and serum in glioma patients reveals diagnostic and prognostic information. Metabolites 2015, 5, 502–520. [CrossRef] [PubMed]
48. Sulek, K.; Han, T.L.; Villas-Boas, S.G.; Wishart, D.S.; Soh, S.E.; Kwek, K.; Gluckman, P.D.; Chong, Y.S.; Kenny, L.C.; Baker, P.N. Hair metabolomics: Identification of fetal compromise provides proof of concept for biomarker discovery. Theranostics 2014, 4, 953–959. [CrossRef] [PubMed]
49. Patel, N.; Alkhouri, N.; Eng, K.; Cikach, F.; Mahajan, L.; Yan, C.; Grove, D.; Rome, E.S.; Lopez, R.; Dweik, R.A. Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: A pilot study. Aliment. Pharmacol. Ther. 2014, 40, 498–507. [CrossRef] [PubMed]
50. Duckwall, C.S.; Murphy, T.A.; Young, J.D. Mapping cancer cell metabolism with 13C flux analysis: Recent progress and future challenges. J. Carcinog. 2013, 12. [CrossRef]
51. Chokkathukalam, A.; Kim, D.-H.; Barrett, M.P.; Breitling, R.; Creek, D.J. Stable isotope-labeling studies in metabolomics: New insights into structure and dynamics of metabolic networks. Bioanalysis 2014, 6, 511–524. [CrossRef] [PubMed]